The Court of Arbitration for Sport (CAS) imposed a four-year suspension on Russian figure skater Kamila Valieva for a doping violation detected before the 2022 Winter Olympics.
Initially, the Russian Anti-Doping Agency (RUSADA) had cleared the then-15-year-old Valieva, who won team gold in Beijing, of any wrongdoing.
However, CAS overturned this decision following an appeal by the World Anti-Doping Agency (WADA), leading to the disqualification of all Valieva’s competitive results starting from 25 December 2021.
WADA expressed approval of the ban, emphasizing the gravity of doping minors and suggesting that doping children should be criminalized.
In contrast, the Kremlin criticized the ruling as “politicized,” and the Russian Olympic Committee (ROC) claimed it was part of a broader attack on Russian sports.
Valieva’s case sparked widespread debate over her responsibility as a minor, the testing process, and the efficacy of the banned substance, trimetazidine, which she attributed to accidental contamination from her grandfather’s medication.
Trimetazidine is known for its potential side effects, casting doubt on its performance-enhancing benefits.
Valieva made history at the Beijing Olympics by being the first female skater to execute a quadruple jump in an Olympic competition, contributing to Russia’s team’s gold victory. The revelation of her positive test for trimetazidine came the day after her historic performance.
The controversy has delayed the medal ceremony for the event, leaving athletes from the United States, Japan, and Canada awaiting official recognition. The CAS ruling has been hailed by some in the U.S. as a win for clean sport, though frustrations linger over the prolonged duration of the case’s resolution.
“While any sense of true justice has been denied by the unbelievable and unnecessary delay in this case, we are incredibly pleased for clean athletes that this sad saga has finally come to an end and hope they can find joy and satisfaction in the fact that their long wait for justice is over,” United States Anti-Doping Agency (USADA) chief executive Travis Tygart said.
